tiprankstipranks
Trending News
More News >
Oryzon Genomics SA (DE:ORN)
FRANKFURT:ORN
US Market

Oryzon Genomics SA (ORN) Ratios

Compare
1 Followers

Oryzon Genomics SA Ratios

DE:ORN's free cash flow for Q2 2025 was €0.00. For the 2025 fiscal year, DE:ORN's free cash flow was decreased by € and operating cash flow was €0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.13 0.75 0.87 1.34 3.76
Quick Ratio
2.13 0.74 0.87 1.34 3.75
Cash Ratio
1.97 0.48 0.75 1.14 3.31
Solvency Ratio
-0.08 -0.16 -0.13 -0.13 -0.19
Operating Cash Flow Ratio
0.00 -0.48 -0.04 -0.10 -0.42
Short-Term Operating Cash Flow Coverage
0.00 -0.65 -0.05 -0.18 -1.06
Net Current Asset Value
€ 8.25M€ -12.93M€ -10.85M€ -5.96M€ 8.48M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.15 0.13 0.17 0.14
Debt-to-Equity Ratio
0.09 0.19 0.17 0.24 0.19
Debt-to-Capital Ratio
0.08 0.16 0.14 0.19 0.16
Long-Term Debt-to-Capital Ratio
0.04 0.08 0.04 0.09 0.13
Financial Leverage Ratio
1.38 1.25 1.31 1.43 1.34
Debt Service Coverage Ratio
0.53 -0.25 -0.12 -0.26 -1.13
Interest Coverage Ratio
-0.36 -3.60 -2.40 -4.91 -15.39
Debt to Market Cap
0.04 0.18 0.13 0.12 0.10
Interest Debt Per Share
0.16 0.27 0.26 0.33 0.27
Net Debt to EBITDA
-1.41K -2.39 -0.32 0.72 2.17
Profitability Margins
Gross Profit Margin
150.80%95.90%98.28%0.00%0.00%
EBIT Margin
-1.61%-62.26%-32.16%0.00%0.00%
EBITDA Margin
0.24%-60.25%-31.24%0.00%0.00%
Operating Profit Margin
-14.49%-60.10%-32.06%0.00%0.00%
Pretax Profit Margin
-94.09%-75.71%-43.01%0.00%0.00%
Net Profit Margin
-33.51%-49.80%-23.63%0.00%0.00%
Continuous Operations Profit Margin
-33.51%-49.81%-23.63%0.00%0.00%
Net Income Per EBT
35.61%65.78%54.93%64.54%65.28%
EBT Per EBIT
649.36%125.96%134.18%119.43%102.42%
Return on Assets (ROA)
-1.69%-3.37%-3.14%-4.08%-4.91%
Return on Equity (ROE)
-2.56%-4.21%-4.10%-5.83%-6.58%
Return on Capital Employed (ROCE)
-0.83%-4.56%-5.03%-6.46%-8.08%
Return on Invested Capital (ROIC)
-0.31%-2.75%-2.44%-3.72%-5.08%
Return on Tangible Assets
-5.96%-31.54%-3.15%-15.19%-13.34%
Earnings Yield
-1.02%-4.07%-2.74%-3.04%-3.29%
Efficiency Ratios
Receivables Turnover
2.62 5.11 0.00 0.00 0.00
Payables Turnover
0.18 0.14 0.07 -3.01 -3.39
Inventory Turnover
37.30 101.47 40.42 -1.55K -95.09
Fixed Asset Turnover
25.98 20.70 29.49 0.00 0.00
Asset Turnover
0.05 0.07 0.13 0.00 0.00
Working Capital Turnover Ratio
0.36 -2.87 6.61 0.00 0.00
Cash Conversion Cycle
-1.83K -2.49K -5.11K 121.12 103.77
Days of Sales Outstanding
139.43 71.42 0.00 0.00 0.00
Days of Inventory Outstanding
9.79 3.60 9.03 -0.23 -3.84
Days of Payables Outstanding
1.98K 2.57K 5.11K -121.35 -107.61
Operating Cycle
149.21 75.02 9.03 -0.23 -3.84
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 -0.09 >-0.01 -0.03 -0.07
Free Cash Flow Per Share
0.00 -0.21 -0.25 -0.29 -0.29
CapEx Per Share
0.00 0.12 0.24 0.25 0.22
Free Cash Flow to Operating Cash Flow
0.00 2.36 26.22 8.72 4.24
Dividend Paid and CapEx Coverage Ratio
0.00 -0.74 -0.04 -0.13 -0.31
Capital Expenditure Coverage Ratio
0.00 -0.74 -0.04 -0.13 -0.31
Operating Cash Flow Coverage Ratio
0.00 -0.35 -0.04 -0.11 -0.26
Operating Cash Flow to Sales Ratio
0.00 -0.77 -0.04 0.00 0.00
Free Cash Flow Yield
0.00%-14.87%-12.32%-11.60%-10.80%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-97.74 -24.59 -36.50 -32.85 -30.39
Price-to-Sales (P/S) Ratio
34.34 12.25 8.62 0.00 0.00
Price-to-Book (P/B) Ratio
2.28 1.04 1.50 1.92 2.00
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 -6.73 -8.12 -8.62 -9.26
Price-to-Operating Cash Flow Ratio
0.00 -15.84 -212.83 -75.23 -39.28
Price-to-Earnings Growth (PEG) Ratio
-2.42 -7.53 1.35 2.19 -0.80
Price-to-Fair Value
2.28 1.04 1.50 1.92 2.00
Enterprise Value Multiple
12.69K -22.71 -27.92 -25.25 -18.53
Enterprise Value
227.43M 100.71M 123.80M 135.11M 127.50M
EV to EBITDA
12.69K -22.71 -27.92 -25.25 -18.53
EV to Sales
30.91 13.69 8.72 0.00 0.00
EV to Free Cash Flow
0.00 -7.52 -8.21 -8.38 -8.29
EV to Operating Cash Flow
0.00 -17.70 -215.32 -73.13 -35.16
Tangible Book Value Per Share
0.16 -0.16 1.34 -0.06 0.21
Shareholders’ Equity Per Share
1.40 1.35 1.34 1.29 1.35
Tax and Other Ratios
Effective Tax Rate
0.61 0.34 0.45 0.35 0.35
Revenue Per Share
0.10 0.11 0.23 0.00 0.00
Net Income Per Share
-0.03 -0.06 -0.06 -0.08 -0.09
Tax Burden
0.36 0.66 0.55 0.65 0.65
Interest Burden
58.49 1.22 1.34 1.19 1.02
Research & Development to Revenue
1.88 0.00 0.44 0.00 0.00
SG&A to Revenue
0.68 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 1.55 0.17 0.28 0.51
Currency in EUR